Samsung Biologics Names John Rim President and CEO

Samsung Biologics named John Rim as its president and CEO effectively immediately. Since 2018, he has served as executive vice president at Samsung Biologics. Previously Rim worked for Genentech/Roche in a variety of senior global leadership roles. He also served in leadership roles at Astellas Pharma.





LATEST NEWS

• HOLOEYE Partners with Fraunhofer IPMS on Microdisplay
  Nov 22, 2024
• PI Expands German Production Site: Week in Brief: 11/22/24
  Nov 22, 2024
• Lightsynq Emerges from Stealth with $18M Series A
  Nov 21, 2024
• REMBRANDT Project Collaborators to Advance Microwave Photonics
  Nov 21, 2024
• Quasicrystals Create Light Vortices to Transmit More Data with Fiber Optics
  Nov 21, 2024
• Study Finds Laser Light Can Cast a Shadow
  Nov 20, 2024
• Lumicell Adds CEO: People in the News: 11/20/24
  Nov 20, 2024
• AeroVironment to Acquire BlueHalo in $4.1B Transaction
  Nov 20, 2024